Asthma Inflammation: How Cytokines and Chemokines Affect Airways

# Cytokines, Chemokines, and Your Airways: How Breathing Science Explains Asthma Inflammation

When researchers at Friedrich-Alexander-University Erlangen-Nürnberg examined blood cells from asthma patients, they found that one molecule — a chemokine receptor called CCR3 — tracked closely with worse lung function and higher eosinophil counts. Their 2025 study, published in the *Journal of Allergy and Clinical Immunology: Global*, reveals how immune signaling molecules coordinate the inflammation that makes breathing difficult for millions of people with allergic asthma.

Cytokines Are the Lung’s Communication Network — and CCR3 Is a Key Receiver

Every breath you take pulls in pollen, dust mite fragments, and other airborne particles. In allergic asthma, the immune system misjudges these harmless materials as threats and launches a full inflammatory response. That response depends on cytokines — small proteins that immune cells release to instruct one another — and chemokines, a specialized subset that acts like a GPS, guiding immune cells to migrate toward the site of inflammation.

Susanne Finotto’s team at the Department of Molecular Pneumology in Erlangen focused on CCR3, a chemokine receptor known mainly for its role in recruiting eosinophils, the white blood cells that accumulate in allergic airways and damage lung tissue. Previous research had placed CCR3 almost exclusively on eosinophils, but newer work shows it also sits on mast cells, macrophages, T cells, and dendritic cells — meaning its influence extends across both arms of the immune system.

What the Erlangen Team Found: Remove CCR3 and the Immune Response Changes Shape

The researchers did two things. First, they measured CCR3 expression in peripheral blood mononuclear cells from healthy controls and asthmatic patients. CCR3 mRNA was elevated in the asthma group, and the level correlated with two clinical markers: lower lung function and higher blood eosinophilia.

Second, they compared wild-type mice with CCR3-deficient mice in a model of allergic asthma. Deleting CCR3 disrupted the familiar TH2-driven, eosinophil-dominated inflammation. But here is the striking part: inflammation did not simply stop. Instead, the immune system rerouted itself. CCR3-deficient mice showed impaired cytokine release and a shift toward an innate-like response dominated by mast cells and neutrophils. CD8 T cells also underwent phenotypic changes, failing to develop into migratory effector memory subsets.

The lesson: blocking one signaling node doesn’t silence an overactive immune system — it redirects it. In humans, neutrophil-dominated asthma is often harder to treat than eosinophilic asthma, which is why drugs targeting single chemokine receptors have disappointed in clinical trials. Inflammation, as our article on breathing patterns and immune cell health explains, is a system property, not a single switch.

IL-6 Shows How Cytokines Reach Into the Mitochondria

A separate 2025 study from Regeneron Pharmaceuticals, published in *Cell Reports*, adds a deeper layer: cytokines don’t just send messages between cells — they reprogram energy production inside them. Jianing Xu and colleagues showed that IL-6, a major pro-inflammatory cytokine elevated in asthma, COPD, and many chronic lung diseases, suppresses mitochondrial function through a specific signaling cascade: the gp130-JAK1/STAT1/3-HIF1α/ERRα axis.

In plain terms: IL-6 binds its receptor gp130 on the cell surface, activates the JAK1 enzyme, which switches on the transcription factors STAT1 and STAT3, which then alter the activity of HIF1α and ERRα — two proteins that control how mitochondria express their energy-producing genes. Chronically inflamed cells literally become energy-poor. Reduced mitochondrial output in airway and immune cells can impair mucociliary clearance, tissue repair, and the ability of lung muscles to sustain work, which is one reason chronic inflammation feels like constant fatigue and breathlessness. A similar inflammatory mechanism underlies findings we covered in how e-cigarette vapor damages airways within 1–3 years.

What This Means for Respiratory Health in Practice

Neither study tested breathing exercises, so no direct claims can be made. But the mechanisms point toward strategies worth discussing with a clinician:

• Keep asthma inflammation suppressed properly. Untreated allergic inflammation keeps cytokines like IL-6 and eosinophil-recruiting chemokines elevated. Inhaled corticosteroids and, where indicated, biologic drugs targeting IL-6, IL-5, or IgE remain first-line tools.
• Manage systemic inflammation. Regular moderate exercise, adequate sleep, and omega-3-rich diets all lower baseline IL-6 levels, which may reduce the mitochondrial suppression Xu’s team described.
• Support autonomic balance. Slow breathing practices, as shown in research on respiratory sinus arrhythmia and coherent breathing, shift the nervous system away from stress states that amplify inflammatory signaling.
• Don’t over-hypothesize from animal data. The CCR3 findings come from mice and observational human correlations; causation in human asthma requires further trials.

Frequently Asked Questions

What are cytokines, and why do they matter for breathing?

Cytokines are signaling proteins that immune cells use to communicate. In asthma, excess cytokines recruit inflammatory cells into airway walls, causing swelling, mucus, and the shortness of breath that characterizes attacks.

Can breathing exercises reduce airway inflammation?

Slow, controlled breathing can calm stress-driven inflammatory signaling, but no breathing technique has been shown to replace asthma medication. Think of breathing practices as a complement to, not a substitute for, prescribed treatment.

Why did removing CCR3 make inflammation worse in some ways?

Because the immune system is redundant. Without CCR3, the body rerouted inflammation through innate pathways involving mast cells and neutrophils — a response often harder to treat than eosinophilic asthma.

What is IL-6 and how does it affect lung cells?

IL-6 is a pro-inflammatory cytokine that, per the 2025 Regeneron study, enters cells’ molecular control rooms and suppresses mitochondrial energy production, potentially weakening tissue repair and immune fitness in chronic inflammation.

Airway inflammation is a conversation among billions of cells, conducted in the language of cytokines and chemokines. Understanding that language — including how CCR3 routes immune traffic and how IL-6 drains cellular energy — is the first step toward smarter, more precise respiratory care.

Sources:
https://pubmed.ncbi.nlm.nih.gov/40115969/
https://pubmed.ncbi.nlm.nih.gov/40056415/
https://pubmed.ncbi.nlm.nih.gov/39947455/
https://pubmed.ncbi.nlm.nih.gov/39899814/
https://pubmed.ncbi.nlm.nih.gov/39846704/